ADVB
HEALTHCAREAdvanced Biomed Inc
$6.78-0.08 (-1.17%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving ADVB Today?
No stock-specific AI insight has been generated for ADVB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.61$25.80
$6.78
Fundamentals
Market Cap$11M
P/E Ratio1.9
EPS$3.52
Dividend Yield—
Dividend / Share—
ROE0.8%
Profit Margin—
Debt / Equity—
Trading
Volume87K
Avg Volume (10D)—
Shares Outstanding1.6M
ADVB News
5 articles- Advanced Biomed Inc. Announces 1 for 20 Share ConsolidationYahoo Finance·Feb 18, 2026
- Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug DiscoveryYahoo Finance·Feb 13, 2026
- Advanced Biomed sells Hong Kong subsidiary for $23,000Yahoo Finance·Dec 31, 2025
- Advanced Biomed Inc. Announces Disposal of its Hong Kong SubsidiaryYahoo Finance·Dec 30, 2025
- Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug DiscoveryYahoo Finance·Sep 19, 2025
All 5 articles loaded
Price Data
Open$5.24
Previous Close$6.86
Day High$5.31
Day Low$5.12
52 Week High$25.80
52 Week Low$3.61
52-Week Range
$3.61$25.80
$6.78
Fundamentals
Market Cap$11M
P/E Ratio1.9
EPS$3.52
Dividend Yield—
Dividend / Share—
ROE0.8%
Profit Margin—
Debt / Equity—
Trading
Volume87K
Avg Volume (10D)—
Shares Outstanding1.6M
About Advanced Biomed Inc
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. The company is headquartered in New York, New York.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—